Fields »
ABOUT
HELP
BLOG

6286 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 126 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ACP2Acid phosphatase 2, lysosomal
Endometrial cancer: 1.04e-4
Expressed in all
ACPPAcid phosphatase, prostate
Tissue enriched153prostate:6368.2
ACPTAcid phosphatase, testicular
Tissue enhancedskin:1.4
testis:2.3
ACSBG1Acyl-CoA synthetase bubblegum family member 1
VesiclesTissue enhancedcerebral cortex:25.7
skin:13.3
ACSBG2Acyl-CoA synthetase bubblegum family member 2
CytosolTissue enriched709testis:291.8
ACSF2Acyl-CoA synthetase family member 2
Nucleoplasm
Microtubules
Cytosol		Renal cancer: 2.17e-4
Urothelial cancer: 2.41e-4
Tissue enhancedkidney:136.1
ACSF3Acyl-CoA synthetase family member 3
Renal cancer: 5.97e-6
Pancreatic cancer: 3.76e-5
Expressed in all
ACSL1Acyl-CoA synthetase long-chain family member 1
Nucleus
Mitochondria		Renal cancer: 1.25e-5
Expressed in all
ACSL3Acyl-CoA synthetase long-chain family member 3
Nucleoli
Lipid droplets		Liver cancer: 2.75e-4
Lung cancer: 8.78e-4
Expressed in all
ACSL4Acyl-CoA synthetase long-chain family member 4
Golgi apparatus
Mitochondria		Urothelial cancer: 5.73e-4
Expressed in all
ACSL5Acyl-CoA synthetase long-chain family member 5
Nucleus
Mitochondria		Endometrial cancer: 1.13e-4
Expressed in all
ACSL6Acyl-CoA synthetase long-chain family member 6
Group enriched6bone marrow:18.0
cerebral cortex:62.1
parathyroid gland:22.1
seminal vesicle:28.7
testis:51.2
ACSM1Acyl-CoA synthetase medium-chain family member 1N/A
Tissue enriched55breast:293.3
ACSM2AAcyl-CoA synthetase medium-chain family member 2A
Liver cancer: 1.41e-5
Group enriched578kidney:284.3
liver:185.7
ACSM2BAcyl-CoA synthetase medium-chain family member 2B
Liver cancer: 3.31e-4
Group enriched85kidney:423.8
liver:261.6
ACSM3Acyl-CoA synthetase medium-chain family member 3
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
Tissue enhancedliver:93.0
ACSM4Acyl-CoA synthetase medium-chain family member 4N/A
Tissue enhancedovary:2.5
testis:2.6
ACSM5Acyl-CoA synthetase medium-chain family member 5
Tissue enhancedliver:142.5
ACSM6Acyl-CoA synthetase medium-chain family member 6N/A
Urothelial cancer: 7.71e-4
Tissue enhancedstomach:1.7
ACSS1Acyl-CoA synthetase short-chain family member 1
Lung cancer: 8.33e-5
Cervical cancer: 9.37e-4
Expressed in all
ACSS2Acyl-CoA synthetase short-chain family member 2
Nucleoplasm
Vesicles
Cytosol		Renal cancer: 2.04e-4
Mixed
ACSS3Acyl-CoA synthetase short-chain family member 3
MitochondriaRenal cancer: 0.00e+0
Mixed
ACTN1Actinin, alpha 1
Plasma membrane
Focal adhesion sites		Renal cancer: 9.08e-10
Lung cancer: 7.63e-5
Head and neck cancer: 2.49e-4
Urothelial cancer: 8.00e-4
Expressed in all
ACVR1Activin A receptor, type I
Urothelial cancer: 5.17e-4
Expressed in all
ACVR1BActivin A receptor, type IB
CytosolExpressed in all
ACVR1CActivin A receptor, type IC
Tissue enriched8adipose tissue:33.9
ACVR2AActivin A receptor, type IIA
CytosolRenal cancer: 1.62e-4
Mixed
ACVR2BActivin A receptor, type IIB
Nucleus
Nuclear bodies
Cytosol		Mixed
ACVRL1Activin A receptor type II-like 1
Tissue enhancedplacenta:125.5
ADAM10ADAM metallopeptidase domain 10
Vesicles
Plasma membrane		Lung cancer: 8.46e-5
Pancreatic cancer: 1.90e-4
Expressed in all
ADAM11ADAM metallopeptidase domain 11
Tissue enhancedcerebral cortex:19.8
ADAM12ADAM metallopeptidase domain 12
Plasma membraneRenal cancer: 2.39e-14
Tissue enriched8placenta:236.1
ADAM15ADAM metallopeptidase domain 15
VesiclesRenal cancer: 5.64e-9
Glioma: 3.49e-5
Liver cancer: 3.49e-4
Expressed in all
ADAM17ADAM metallopeptidase domain 17
CytosolUrothelial cancer: 4.23e-5
Expressed in all
ADAM18ADAM metallopeptidase domain 18
Tissue enriched84testis:8.3
ADAM19ADAM metallopeptidase domain 19
VesiclesRenal cancer: 3.90e-12
Mixed
ADAM2ADAM metallopeptidase domain 2
Tissue enriched288testis:41.7
ADAM20ADAM metallopeptidase domain 20
Tissue enriched76testis:9.2
ADAM21ADAM metallopeptidase domain 21
Tissue enriched31testis:15.4
ADAM22ADAM metallopeptidase domain 22
Cell JunctionsTissue enhancedcerebral cortex:47.7
ADAM23ADAM metallopeptidase domain 23
Group enriched6cerebral cortex:55.7
parathyroid gland:132.9
ADAM28ADAM metallopeptidase domain 28
Plasma membrane
Mitochondria		Endometrial cancer: 3.17e-4
Tissue enhancedepididymis:428.3
ADAM29ADAM metallopeptidase domain 29
Tissue enriched80testis:72.8
ADAM30ADAM metallopeptidase domain 30
Tissue enriched468testis:46.8
ADAM32ADAM metallopeptidase domain 32
Nucleus
Vesicles		Tissue enriched31testis:28.7
ADAM33ADAM metallopeptidase domain 33
Nuclear speckles
Plasma membrane		Mixed
ADAM7ADAM metallopeptidase domain 7
Tissue enriched198epididymis:4461.2
ADAM8ADAM metallopeptidase domain 8
Renal cancer: 3.99e-10
Tissue enhancedbone marrow:43.9
spleen:33.5
ADAM9ADAM metallopeptidase domain 9
Endoplasmic reticulum
Vesicles		Liver cancer: 7.21e-6
Pancreatic cancer: 2.52e-5
Breast cancer: 1.14e-4
Cervical cancer: 2.25e-4
Renal cancer: 3.99e-4
Expressed in all
ADAMDEC1ADAM-like, decysin 1
Tissue enhancedcolon:214.7
rectum:344.3
small intestine:485.5

« prev | Page of 126 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.